Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04482062
Other study ID # 2020-05
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 9, 2021
Est. completion date December 31, 2029

Study information

Verified date January 2024
Source Edwards Lifesciences
Contact TMTT Clinical
Phone 949-250-2500 or 800-424-3278
Email TMTT_Clinical@Edwards.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system


Description:

The study is a prospective, multi-center, randomized controlled pivotal clinical trial to evaluate the safety and effectiveness of the EVOQUE System with optimal medical therapy (OMT) compared to OMT alone in the treatment of patients with at least severe tricuspid regurgitation. Subjects will be followed at discharge, 30 days, 3 months, 6 months and annually through 5 years.


Recruitment information / eligibility

Status Recruiting
Enrollment 1070
Est. completion date December 31, 2029
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Symptomatic tricuspid regurgitation (TR) despite medical therapy - TR graded as severe or greater - Appropriate for transcatheter tricuspid valve replacement per the local heart team Exclusion Criteria: - Tricuspid valve anatomic contraindications - Need for emergent or urgent surgery or any planned cardiac surgery within the next 12 months - Hemodynamic instability - Refractory heart failure requiring advanced intervention - Currently participating in another investigational study

Study Design


Intervention

Device:
Edwards EVOQUE System
Transcatheter tricuspid valve replacement with the Edwards EVOQUE System in conjunction with OMT
Drug:
Optimal Medical Therapy
Optimal Medical Therapy

Locations

Country Name City State
Germany Herz- und Diabeteszentrum NRW, Bad Oeynhausen Bad Oeynhausen
Germany Herzzentrum Universitätsklinik Bonn Bonn
Germany Herzzentrum Dresden Universitätsklinik Dresden
Germany Herzzentrum der Uniklinik Köln Köln
Germany Herzzentrum Leipzig GmbH Leipzig
Germany Johannes Gutenberg-Universität Mainz Mainz
Germany Klinikum der Universität München - Großhadern München
United States University of Michigan Hospital and Health Systems Ann Arbor Michigan
United States Emory University Atlanta Georgia
United States Piedmont Heart Institute Atlanta Georgia
United States Florida Heart & Vascular Care - JFK Atlantis Florida
United States Johns Hopkins Hospital Baltimore Maryland
United States University of Maryland Baltimore Maryland
United States Beth Israel Deaconess Medical Center Boston Massachusetts
United States Brigham and Women's Hospital Boston Massachusetts
United States Massachusetts General Hospital Boston Massachusetts
United States Montefiore Medical Center Bronx New York
United States State University of New York at Buffalo Buffalo New York
United States University of North Carolina - Chapel Hill Chapel Hill North Carolina
United States Carolinas Medical Center Charlotte North Carolina
United States University of Virginia Health System Charlottesville Virginia
United States Northwestern University Chicago Illinois
United States The Christ Hospital Cincinnati Ohio
United States Cleveland Clinic Cleveland Ohio
United States Henry Ford Health System Detroit Michigan
United States The Cardiac & Vascular Institute Research Foundation Gainesville Florida
United States HCA Houston Healthcare Houston Texas
United States The University of Texas Health Science Center at Houston Houston Texas
United States St. Vincent Heart Center of Indiana Indianapolis Indiana
United States Kansas University Medical Center Kansas City Kansas
United States Saint Luke's Hospital of Kansas City Kansas City Missouri
United States Scripps Memorial Hospital La Jolla La Jolla California
United States Cedars-Sinai Medical Center Los Angeles California
United States Medical Center of the Rockies Loveland Colorado
United States North Shore University Hospital Manhasset New York
United States Morristown Medical Center Morristown New Jersey
United States Intermountain Medical Center Murray Utah
United States NCH Heart Institute Naples Florida
United States Saint Thomas Health Nashville Tennessee
United States Vanderbilt University Medical Center Nashville Tennessee
United States Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey
United States Columbia University Medical Center/NYPH New York New York
United States Lenox Hill Hospital New York New York
United States NYU Langone Health New York New York
United States Weill Cornell Medicine-New York Presbyterian Hospital New York New York
United States Sentara Norfolk General Hospital Norfolk Virginia
United States University of Pennsylvania Philadelphia Pennsylvania
United States SJHMC Heart and Vascular Institute Phoenix Arizona
United States Baylor Heart Hopsital Plano Plano Texas
United States Oregon Health & Science University Portland Oregon
United States Mayo Clinic Rochester Minnesota
United States Rochester General Hospital Rochester New York
United States St. Francis Hospital Roslyn New York
United States UC Davis Medical Center Sacramento California
United States Washington University Barnes-Jewish Hospital Saint Louis Missouri
United States Kaiser Permanente San Francisco San Francisco California
United States University of California San Francisco San Francisco California
United States Swedish Medical Center Seattle Washington
United States University of Washington Seattle Washington
United States Virginia Mason Franciscan Health Seattle Washington
United States Stanford University Stanford California
United States Tucson Medical Center Tucson Arizona
United States Oklahoma Heart Institute Tulsa Oklahoma
United States Cardiovascular Research Institute of Kansas Wichita Kansas
United States Lankenau Heart Institute Wynnewood Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Edwards Lifesciences

Countries where clinical trial is conducted

United States,  Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary TR Grade reduction and composite endpoint including: Kansas City Cardiomyopathy Questionnaire (KCCQ) improvement, New York Heart Association (NYHA) functional class improvement, and 6-minute walk test distance improvement Comparison of number of participants with reduction in TR and composite endpoint event improvement between experimental and active comparator arms 6 months
Primary Rate of Major Adverse Events (MAE) Rate of Major Adverse Events (MAE) in experimental arm 30 days
Primary Composite endpoint including all-cause mortality, RVAD implantation or heart transplant, tricuspid valve intervention, heart failure hospitalizations, KCCQ improvement, NYHA functional class improvement, and 6-minute walk distance improvement Comparison of number of participants with composite endpoint events between experimental and active comparator arms 1 year
Secondary Composite endpoint including reduction in TR grade, change in QOL from baseline, death and heart failure hospitalization, all-cause hospitalization, all-cause mortality, and change in right ventricular end diastolic volume index Hierarchical comparison of number of participants with composite endpoint events between experimental and active comparator arms 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy